Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Karran

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Methods in Molecular Medicine|February 15, 2011
Development of Neoepitope Antibodies Against the β-Secretase Cleavage Site in the Amyloid Precursor ProteinC W Gray, E H Karran
Matrix (Stuttgart, Germany). Supplement|January 1, 1992
An in vivo model of collagen degradationE H Karran, G P Harper
Journal of Pharmacological and Toxicological Methods|October 1, 1995
Collagen degradation within subcutaneous air pouches in vivo: the effects of proteinase inhibitorsE H Karran, G P Harper
FEBS Letters|January 7, 1999
A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contractionK A Scott, E J Wood, E H Karran
The Biochemical Journal|January 15, 1997
Membrane protein secretasesN M Hooper, E H Karran, A J Turner
FEBS Letters|July 31, 1998
The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertaseS Parvathy, E H Karran, A J Turner, et al.
Biochemical Society Transactions|March 27, 1999
Angiotensin-converting enzyme and the amyloid precursor protein secretasesN M Hooper, S Parvathy, E H Karran, et al.
Annals of the Rheumatic Diseases|August 1, 1995
In vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitorE H Karran, T J Young, R E Markwell, et al.
Biochemical Society Transactions|October 10, 1998
The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitorsS Parvathy, I Hussain, E H Karran, et al.
Biochemistry|March 4, 1998
Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretaseS Parvathy, I Hussain, E H Karran, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Medicine|February 15, 2011
Development of Neoepitope Antibodies Against the β-Secretase Cleavage Site in the Amyloid Precursor ProteinC W Gray, E H Karran
Matrix (Stuttgart, Germany). Supplement|January 1, 1992
An in vivo model of collagen degradationE H Karran, G P Harper
Journal of Pharmacological and Toxicological Methods|October 1, 1995
Collagen degradation within subcutaneous air pouches in vivo: the effects of proteinase inhibitorsE H Karran, G P Harper
FEBS Letters|January 7, 1999
A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contractionK A Scott, E J Wood, E H Karran
The Biochemical Journal|January 15, 1997
Membrane protein secretasesN M Hooper, E H Karran, A J Turner
FEBS Letters|July 31, 1998
The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertaseS Parvathy, E H Karran, A J Turner, et al.
Biochemical Society Transactions|March 27, 1999
Angiotensin-converting enzyme and the amyloid precursor protein secretasesN M Hooper, S Parvathy, E H Karran, et al.
Annals of the Rheumatic Diseases|August 1, 1995
In vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitorE H Karran, T J Young, R E Markwell, et al.
Biochemical Society Transactions|October 10, 1998
The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitorsS Parvathy, I Hussain, E H Karran, et al.
Biochemistry|March 4, 1998
Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretaseS Parvathy, I Hussain, E H Karran, et al.
Pageof 3